(AIBU) - Overview
Etf: AI, Big Data, US Equities
Dividends
| Dividend Yield | 2.10% |
| Yield on Cost 5y | 4.48% |
| Yield CAGR 5y | 138.94% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 64.1% |
| Relative Tail Risk | 4.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | -19.87 |
| Character TTM | |
|---|---|
| Beta | 2.887 |
| Beta Downside | 2.706 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.17% |
| CAGR/Max DD | 0.80 |
Description: AIBU December 23, 2025
The Solactive-designed AIBU index tracks U.S. companies whose core revenues stem from artificial-intelligence applications and big-data technologies. Direxion’s AIBU ETF seeks to replicate this index, allocating at least 80 % of net assets (plus any permitted borrowing) to index-linked instruments such as swaps, futures, or other ETFs, and is classified as a non-diversified, leveraged equity fund.
Key market context: the U.S. AI software and services market is projected to grow at a CAGR of roughly 23 % through 2028, driven by expanding cloud-infrastructure spending and rising adoption of generative AI in enterprise workflows. Concentration risk is notable-over 40 % of the index’s weight is typically held by a handful of mega-cap firms (e.g., Microsoft, Nvidia, Alphabet), amplifying both upside potential and volatility. Leveraged exposure further magnifies returns and losses, so investors should monitor the fund’s net-asset-value (NAV) volatility relative to its 2× or 3× target exposure.
For a deeper dive into how AIBU’s performance aligns with broader AI adoption trends, you might explore ValueRay’s analytics platform for granular, real-time factor breakdowns.
What is the price of AIBU shares?
Over the past week, the price has changed by -5.88%, over one month by -12.10%, over three months by -21.02% and over the past year by +15.44%.
Is AIBU a buy, sell or hold?
What are the forecasts/targets for the AIBU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 46.7 | 3.3% |
AIBU Fundamental Data Overview February 10, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 27.1m USD (27.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 27.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 27.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 16.55% (E(27.1m)/V(27.1m) * Re(16.55%) + (debt-free company))
Discount Rate = 16.55% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)